NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Ischemia Reperfusion Injury, Myocardial Injury, Acute Kidney Injury

In brief

A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery

Key facts

Study ID
NCT04750616
Run by
Kaiser Permanente
People needed
304
Starts
2021-09-13
Expected to finish
2025-06-30
Last updated by the study team
2025-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.